Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients. - Wikidata - awgldk - TriplyDB

Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.

Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.

http://www.wikidata.org/entity/Q54594035

about

PP2A: The Achilles Heal in MDS with 5q Deletion Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.Update on cytogenetic and molecular changes in myelodysplastic syndromes.Acute Myeloid Leukemia With Myelodysplasia-Related Changes.Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.

P2860

Q27690852-87ED3AA9-63C1-4E0D-A851-5F8DC746FF24 Q27851680-708E59E6-BD51-4498-BAE2-48748700A1D4 Q33779309-44740502-C985-44BE-8E23-885B097F2F71 Q35835653-39BDC2FD-B5C1-4A23-ABD3-683CC4090F7E Q37377901-A8374DC2-FAB5-4432-8F05-3710888B28BC Q37923939-6A5AEE23-B408-4F36-B445-9B11624EA520 Q38526939-950342C8-40CF-4400-9D5D-820B021BEC2A Q45155324-E21796E2-CF97-4357-BEC2-087B2E796302 Q53090060-D72E8833-08CC-4954-B7E7-2FEFC649EFC4

P2860

Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.

http://www.wikidata.org/entity/Q54594035

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Isolated del(5q) in myeloid ma ...... s in 143 consecutive patients.

@en

type

label

Isolated del(5q) in myeloid ma ...... s in 143 consecutive patients.

@en

prefLabel

Isolated del(5q) in myeloid ma ...... s in 143 consecutive patients.

@en

P1433

Q54594035-47D27E38-F27A-453F-94A5-34284F760BFB

P1476

Q54594035-44BA8EF8-1952-4CAF-B852-50C5DE009236

P2093

Q54594035-19C096E2-11B2-4FB5-814B-581AEF037D97

Q54594035-36DB9D9F-50C7-4803-9943-135D7DB19F4F

Q54594035-3D7D59B5-7F69-4BE8-A5B9-BEFB47D64FC8

Q54594035-6D11F255-8F7D-4418-9E6C-8FCA958FA992

Q54594035-7B7E31EC-1486-4527-ABDD-2BB0DF71374C

Q54594035-AF4619F8-D745-4307-BEAB-609D858316A3

Q54594035-B5A6FA35-75E7-427B-A51A-C0AFBC774AE7

P2860

Q54594035-108250A7-DF48-416E-ACC8-7116AE94CB5C

Q54594035-1E9F7F80-9C6B-4E8E-9278-64802CD58620

Q54594035-28433890-016F-4E0A-A416-B7F880F045F8

Q54594035-2A0B91DF-A85D-4491-9C78-682A9280BD32

Q54594035-32E0A024-75AD-4BB6-A59D-957FA4418C87

Q54594035-412A3E3E-CCA0-4083-AD16-46E26069F2A6

Q54594035-49167A4F-FA56-48A9-9EC7-EA936CAD60B5

Q54594035-58DB5623-9FA7-490B-B89C-27361923475B

Q54594035-69EE81AB-6691-4155-A902-3BA0BBDE2643

Q54594035-8896618D-D983-472E-8269-51389E22EF9F

P304

Q54594035-13CB170C-BBE7-4904-83FF-CE1913B4A4B7

P31

Q54594035-9AB265C9-1B84-407E-B32B-6DB572AD15B4

P356

Q54594035-0B767D6E-F227-4D26-A668-C6382F655D6A

P433

Q54594035-65D3F558-D948-40B0-A16C-9F590B57F136

P478

Q54594035-5677919A-1A71-4594-83D8-B52B0E3188BE

P50

Q54594035-399A2136-6FED-4A34-BA79-BF2428B7CD65

Q54594035-C5068116-6AF4-43E8-9F32-F6BCAA693ADE

P577

Q54594035-1893EF0A-E148-4DFD-99A4-2448B43FC32A

P5875

Q54594035-6B3992AD-D1C2-4003-A766-9C87ADC07789

P698

Q54594035-59D65FE8-8A8F-47E7-B360-B50FF76BF5ED

P356

P1433

American Journal of Hematology

P1476

Isolated del(5q) in myeloid ma ...... s in 143 consecutive patients.

@en

P2093

Christy M Finke

http://www.w3.org/2001/XMLSchema#string

Curtis A Hanson

http://www.w3.org/2001/XMLSchema#string

Dong Chen

http://www.w3.org/2001/XMLSchema#string

James D Hoyer

http://www.w3.org/2001/XMLSchema#string

Mrinal M Patnaik

http://www.w3.org/2001/XMLSchema#string

Ryan A Knudson

http://www.w3.org/2001/XMLSchema#string

Terra L Lasho

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Recurring mutations found by sequencing an acute myeloid leukemia genome

IDH1 and IDH2 mutations in gliomas

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.

Efficacy of lenalidomide in myelodysplastic syndromes.

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.

Diagnosis, genetics, and management of inherited bone marrow failure syndromes.

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations.

P304

393-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.21984

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Rhett P. Ketterling

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51080513

http://www.w3.org/2001/XMLSchema#string

P698

21523797

http://www.w3.org/2001/XMLSchema#string